WeVote

Bill

Bill

HB 25

AN ACT relating to coverage for scalp cooling systems used in connection with chemotherapy treatment for breast cancer.

2026 Regular Session Introduced by George Brown and 3 co-sponsors

Requires Kentucky health insurers to cover scalp cooling systems for breast cancer chemotherapy patients to prevent hair loss, removing financial barriers to this supportive treatment.

to Banking & Insurance (H)
0
WeVote Research Nonpartisan
Bill Summary · HB 25

Legislative bill overview

HB 25 would require health insurance coverage for scalp cooling systems used during chemotherapy treatment for breast cancer patients. Scalp cooling technology works by reducing scalp temperature during chemo infusions, which can help prevent or reduce chemotherapy-induced hair loss (alopecia). The bill aims to ensure insurance plans cover this treatment option rather than leaving patients to pay out-of-pocket.

Why is this important

Chemotherapy-induced hair loss significantly impacts breast cancer patients' quality of life and psychological well-being during already-traumatic treatment. While scalp cooling systems exist and are FDA-approved, they can cost $3,000-$5,000 per treatment course, creating a financial barrier for many patients. Insurance coverage requirements would make this supportive care option accessible to more patients regardless of economic status.

Potential points of contention

  • Insurance cost impact: Insurers may argue this increases premiums or deductibles since scalp cooling is considered supportive rather than curative care
  • Medical necessity debate: Some insurers classify this as optional/cosmetic rather than medically necessary, though patient advocacy groups dispute this framing
  • Implementation scope: Unclear whether the bill covers all insurance types (commercial, Medicaid, Medicare) or only specific plans, and whether it includes all system types or specific brands

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.